Geneva Capital Management’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $76M | Buy |
915,238
+51,489
| +6% | +$4.28M | 1.27% | 25 |
|
|
2025
Q1 | $72.5M | Sell |
863,749
-1,833
| -0.2% | -$154K | 1.35% | 22 |
|
|
2024
Q4 | $79.8M | Sell |
865,582
-12,263
| -1% | -$1.13M | 1.38% | 24 |
|
|
2024
Q3 | $81.5M | Sell |
877,845
-1,682
| -0.2% | -$156K | 1.36% | 24 |
|
|
2024
Q2 | $72.4M | Sell |
879,527
-20,511
| -2% | -$1.69M | 1.32% | 28 |
|
|
2024
Q1 | $59.7M | Sell |
900,038
-4,686
| -0.5% | -$311K | 1.05% | 33 |
|
|
2023
Q4 | $51.4M | Sell |
904,724
-1,904
| -0.2% | -$108K | 0.97% | 39 |
|
|
2023
Q3 | $49.4M | Buy |
906,628
+4,266
| +0.5% | +$232K | 1.04% | 32 |
|
|
2023
Q2 | $60.7M | Sell |
902,362
-4,610
| -0.5% | -$310K | 1.2% | 30 |
|
|
2023
Q1 | $46.7M | Buy |
906,972
+13,660
| +2% | +$703K | 0.95% | 41 |
|
|
2022
Q4 | $41.1M | Buy |
893,312
+1,474
| +0.2% | +$67.8K | 0.92% | 42 |
|
|
2022
Q3 | $45.2M | Buy |
891,838
+35,059
| +4% | +$1.78M | 1.04% | 35 |
|
|
2022
Q2 | $39M | Sell |
856,779
-10,038
| -1% | -$457K | 0.9% | 45 |
|
|
2022
Q1 | $40.3M | Sell |
866,817
-9,890
| -1% | -$460K | 0.78% | 54 |
|
|
2021
Q4 | $44M | Sell |
876,707
-20,189
| -2% | -$1.01M | 0.71% | 59 |
|
|
2021
Q3 | $47.6M | Sell |
896,896
-6,826
| -0.8% | -$362K | 0.81% | 53 |
|
|
2021
Q2 | $55.1M | Sell |
903,722
-15,853
| -2% | -$967K | 0.9% | 42 |
|
|
2021
Q1 | $44.9M | Sell |
919,575
-22,056
| -2% | -$1.08M | 0.77% | 54 |
|
|
2020
Q4 | $38.1M | Buy |
941,631
+26,583
| +3% | +$1.08M | 0.65% | 64 |
|
|
2020
Q3 | $29.8M | Buy |
915,048
+23,156
| +3% | +$753K | 0.61% | 71 |
|
|
2020
Q2 | $23.5M | Buy |
891,892
+22,551
| +3% | +$595K | 0.51% | 76 |
|
|
2020
Q1 | $21.7M | Buy |
+869,341
| New | +$21.7M | 0.62% | 69 |
|